NEW YORK--(BUSINESS WIRE)--Massive Bio today announced it has entered a partnership with Veterans Prostate Cancer Awareness (VPCa), and Self-Care Catalysts to increase clinical trial and real-world ...
Cancer trial matchmaker Massive Bio is teaming up with two organizations to boost clinical studies and research participation for prostate cancer. Massive Bio, Veterans Prostate Cancer Awareness and ...
MINNEAPOLIS, June 11, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of ...
Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "U.S. Prostate Cancer Biomarkers Market Size, Share & Trends Analysis 2025-2033" has been added to ResearchAndMarkets.com's offering. The U.S. prostate ...
When implementing the ExoDx™ Prostate test in a real-world clinical setting, patients demonstrated improved compliance with the physician's recommendation to defer prostate biopsy when the test was ...
BOCA RATON, FL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, is pleased to report that its Phase I/II trial ...
Bio-Techne’s urine test, designed to track down the exosomes and genomic markers released from prostate cancer cells, has received a breakthrough device designation from the FDA for ruling out ...
A Point Biopharma Global cancer therapy key to a $1.4 billion Eli Lilly M&A deal has met the main goal of its pivotal clinical trial in prostate cancer. But the results raise questions about how well ...
LOS ANGELES - INmune Bio , Inc. (NASDAQ:INMB), a clinical-stage biotech company valued at $175 million, has announced the treatment of the first patient in the Phase II segment of its ongoing clinical ...
Sophiris Bio Inc. SPHS, a biopharmaceutical company developing PRX302 (topsalysin) for the treatment of urological diseases, revealed the biopsy results from all 18 patients enrolled in the Phase 2a ...
Bio-Techne Corp. is expanding into the realm of diagnostics with its ExoDx Prostate cancer test and a development pipeline of comparable products — a new area of business for the company, best known ...
Trinity Biotech plc a annoncé la conclusion d'une collaboration stratégique avec une société leader en bio-informatique afin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback